Barclays lowered the firm’s price target on Adient (ADNT) to $24 from $27 and keeps an Equal Weight rating on the shares. The firm issued a soft fiscal 2026 outlook on volume and mix, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT: